What does CUSIP 816212104 represent in this 13F holders report?

CUSIP 816212104 is the security identifier for RNAC - SELECTA BIOSCIENCES INC - COM used to aggregate holder disclosures.

How many institutions held RNAC - SELECTA BIOSCIENCES INC - COM in Q3 2020?

74 institutional investors reported RNAC - SELECTA BIOSCIENCES INC - COM for Q3 2020. Use the holders table for investor-level position and value details.

SELECTA BIOSCIENCES INC - COM (RNAC)

CUSIP: 816212104

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class: Equity / COM
Total 13F shares: 55,696,891
Share change: +959,547
Total reported value: $138,133,555
Put/Call ratio: 42%
Price per share: $2.48
Number of holders: 74
Value change: +$1,634,822
Number of buys: 35
Number of sells: 38

Quarterly Holders Quick Answers

What is CUSIP 816212104?
CUSIP 816212104 identifies RNAC - SELECTA BIOSCIENCES INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2020
Previous quarter: Q2 2020

Recent filing periods for CUSIP 816212104:

Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022

Institutional Holders of SELECTA BIOSCIENCES INC - COM (RNAC) as of Q3 2020

As of 30 Sep 2020, SELECTA BIOSCIENCES INC - COM (RNAC) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,696,891 shares. The largest 10 holders included BVF INC/IL, VANGUARD GROUP INC, Artal Group S.A., BlackRock Inc., BOXER CAPITAL, LLC, Marshall Wace North America L.P., Polaris Venture Management Co. V, L.L.C., FMR LLC, ACUTA CAPITAL PARTNERS, LLC, and ORBIMED ADVISORS LLC. This page lists 74 institutional shareholders reporting positions in this security for the Q3 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.